These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 27470625

  • 1. [Clinical value of contrast-enhanced ultrasound in evaluating portal hypertension in patients with decompensated liver cirrhosis].
    Zhuang Y, Ding H, Han H, Mao F, Luo JJ, Chen SY, Wang WP.
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):270-4. PubMed ID: 27470625
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY, Baik SK, Park DH, Lim DW, Kim JW, Kim HS, Kwon SO, Kim YJ, Chang SJ, Lee SS.
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.
    Jeong WK, Kim TY, Sohn JH, Kim Y, Kim J.
    PLoS One; 2015 Oct; 10(3):e0121601. PubMed ID: 25798930
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative diagnosis of early-stage liver cirrhosis with contrast-enhanced ultrasound--a clinical study.
    Shi Y, Wang XH, Xia GC, Lei CG.
    Adv Clin Exp Med; 2012 Oct; 21(3):385-90. PubMed ID: 23214202
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hepatic transit times and liver elasticity compared with meld in predicting a 1 year adverse clinical outcome of a clinically diagnosed cirrhosis].
    Koller T, Piešťanská Z, Hlavatý T, Holomáň J, Glasa J, Payer J.
    Vnitr Lek; 2016 Oct; 62(5):351-9. PubMed ID: 27319227
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.
    Choi SY, Jeong WK, Kim Y, Kim J, Kim TY, Sohn JH.
    Radiology; 2014 Dec; 273(3):917-26. PubMed ID: 25025464
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Analysis of 833 times measured hepatic venous pressure gradient].
    Zhang MY, Wang GC, Huang GJ, Feng H, Wang LF, Zhang JY, Shi YJ, Zhang CQ.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):266-270. PubMed ID: 29996337
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Noninvasive analysis of portal pressure by contrast-enhanced sonography in patients with cirrhosis.
    Zhang CX, Hu J, Hu KW, Zhang C, Wang L, Xu JM.
    J Ultrasound Med; 2011 Feb 20; 30(2):205-11. PubMed ID: 21266558
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.